299 articles
Pritesh Shah, Chief Commercial Officer of device maker Novocure® discusses Tumor Treating Fields, a cap-like device that aims electric fields at cancer...
David Spetzler, President and Chief Scientific Officer of Caris Life Sciences, discusses the company's launch of CODEai™(Comprehensive Oncology Data E...
Susan, a woman living with an NTRK gene fusion, a rare genomic driver that drove her thyroid cancer shares her unique cancer journey and how she benefit
Jim Palma, Executive Director at TargetCancer Foundation discusses a new clinical trial called TRACK (TargetRare Cancer Knowledge).
The Incyte Ingenuity Award is an annual program that was created to support people living with graft-versus-host disease (GVHD). GVHD is a potentially...
Michael Korn, Chief Medical Officer at Caris® Life Sciences discusses new data presented at the European Society for Medical Oncology (ESMO) Virtual Co...
Caron Jacobson, MD, Clinical Director, Immune Effector Cell Therapy Program, Dana-Farber Cancer Institute discusses the blood cancers lymphoma and leuke...
Courtney DiNardo of the MD Anderson Cancer Center discusses the difficult to treat acute myeloid leukemia (AML). She shares findings from the phase 3 ...
Andrew (Andy) Krivoshik, MD, Ph.D., SVP, and Oncology Therapeutic Head for Astellas Oncology shares his perspective on this year's C3 Prize (Changing Ca...
Returning guest, Bill Rancic discusses his ongoing partnership with the Astellas Oncology C3 Prize (Changing Cancer Care) program. The C3 Prize is a g...